EventsThe 5th International Electronic Conference on Brain Sciences & 1st International Electronic Conference on Neurosciences
Published
This submission belongs to the session S1. Neurodegenerative Diseases of the event The 5th International Electronic Conference on Brain Sciences & 1st International Electronic Conference on Neurosciences
Published date
04 Mar, 2026
Academic Editor
author-avatarGrazyna Lietzau
Citation
Carlos Domínguez-Vargas, Miranda Citlali Pérez-Castellón, Paloma Marylí Prado-López, Barbarita Sánchez-Peña, Samantha Jonnue Ramírez-Flores, Association Between Salivary Cortisol, Xerostomia, and Nitric Oxide Levels in Patients With Multiple Sclerosis: A Cross-Sectional Study, in Proceedings of The 5th International Electronic Conference on Brain Sciences & 1st International Electronic Conference on Neurosciences, 9 March–11 March 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Association Between Salivary Cortisol, Xerostomia, and Nitric Oxide Levels in Patients With Multiple Sclerosis: A Cross-Sectional Study

image
Paloma Marylí Prado-López 2
Miranda Citlali Pérez-Castellón 1
Samantha Jonnue Ramírez-Flores 1
1. Medicine and Surgery, University Center of Health Sciences (CUCS), University of Guadalajara, Guadalajara, 44430, Mexico., Mexico
2. Neuropsychology, University Center of Health Sciences (CUCS), University of Guadalajara, Guadalajara, 44340, Mexico., Mexico
3. Dental Surgery, Faculty of Dentistry, Universidad Michoacana de San Nicolás de Hidalgo (UMSNH), Morelia, 58010, Mexico., Mexico
Abstract

Introduction: Multiple sclerosis (MS) is characterized by neuroinflammation, autonomic dysfunction, and alterations in the hypothalamic–pituitary–adrenal (HPA) axis. Salivary cortisol is a useful biomarker of physiological stress, while xerostomia and nitric oxide (NO) dysregulation may reflect autonomic or inflammatory changes frequently observed in MS. However, the relationship between cortisol, NO, xerostomia, and anxiety symptoms remains unclear. This study aimed to evaluate the associations among these biomarkers and clinical features in patients with MS.

Methods: A cross-sectional study was conducted in 39 patients with MS. Salivary cortisol and NO were measured through validated assays. Xerostomia was assessed using the Abslang Test (0 = no xerostomia, 1 = xerostomia). Anxiety levels were measured using the Beck Anxiety Inventory (BAI). MS duration was converted to years for analysis. Due to non-normal distributions, Spearman correlations and Mann–Whitney U tests were applied. Logistic regression was performed to examine the predictive value of cortisol for xerostomia, expressed as odds ratios (OR).

Results: Xerostomia was present in 41% of participants. Cortisol levels were higher in patients with xerostomia compared with those without (median 6.02 vs. 4.56; p = 0.050). Logistic regression showed that cortisol increased the odds of xerostomia by 33% per unit increase (OR = 1.33; 95% CI: 0.96–1.85; p = 0.085). Cortisol showed a weak-to-moderate positive correlation with xerostomia (ρ = 0.32; p = 0.047) and a moderate negative correlation with NO (ρ = –0.46; p = 0.0035). No associations were found between cortisol and age, MS duration, or anxiety scores.

Conclusions: Salivary cortisol is associated with xerostomia and lower NO levels in MS, suggesting a possible neuroendocrine–salivary pathway. Although the predictive effect of cortisol on xerostomia did not reach statistical significance, the consistent trends across analyses support a potential physiological link. Larger studies are warranted to further explore these interactions.

Keywords
Multiple Sclerosis
Salivary Cortisol
Xerostomia
Nitric Oxide
Biomarkers
Clinical and Paraclinical Predictors of Conversion from Clinically Isolated Syndrome to Multiple Sclerosis: A Retrospective Cohort Study
Neuroprotective Effects of CS-PLGA@Au Nanocomposites Against Amyloid-β aggregation and Oxidative Stress in In Vitro and In Vivo Models of Alzheimer’s Disease